Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18-60 years: Randomized, controlled, phase III trial

Human Vaccines

Volumn 6, Issue 4, 2010, Pages 346-354

  Arnou, Robert ^a   Eavis, Patrick ^a   De Juanes Pardo, José Ramon ^b   Ambrozaitis, Arvydas ^c   Kazek, Marie Pierre ^d   Weber, Françoise ^d  

^a Hospital '12 de Octubre' ^*

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c VILNIUS UNIVERSITY   (Lithuania)

^d SANOFI PASTEUR   (France)

Author keywords

Adults; Antibody response; Immunogenicity; Inactivated vaccines; Influenza vaccines; Intradermal injection; Lot consistency

Indexed keywords

INFLUENZA VACCINE;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; ECCHYMOSIS; FEMALE; FEVER; HEADACHE; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INJECTION SITE REACTION; INJECTION SITE SWELLING; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTICENTER STUDY; MYALGIA; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SHIVERING;

EID: 77953629692     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.6.4.10961     Document Type: Article

References (28)

1. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333-40.
2. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-86.
3. Liddle BJ, Jennings R. Influenza vaccination in old age. Age Ageing 2001; 30:385-9.
4. Nichol KL. The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 2003; 21:1769-75.
5. Nichol KL, Treanor JJ. Vaccines for seasonal and pandemic influenza. J Infect Dis 2006; 194:111-8.
6. WHO. Influenza vaccines. Weekly epidemiological record 2005; 33:279-87.
7. Nichol KL, D'Heilly SJ, Greenberg ME, Ehlinger E. Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50-64 years. Clin Infect Dis 2009; 48:292-8.
8. Centers for Disease Control and Prevention (CDC). Estimated influenza vaccination coverage among adults and children - United States, September 1, 2004-January 31, 2005. MMWR Morb Mortal Wkly Rep 2005; 54:304-7.
9. Blank PR, Schwenkglenks M, Szucs TD. Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health 2008; 8:272.
10. van Essen GA, Palache AM, Forleo E, Fedson DS. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 2003; 21:1780-5.
11. Mereckiene J, Cotter S, Nicoll A, Levy-Bruhl D, Ferro A, Tridente G, et al. National seasonal influenza vaccination survey in Europe, 2008. Euro Surveill 2008; 13:19017.
12. Ryan J, Zoellner Y, Gradl B, Palache B, Medema J. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries. Vaccine 2006; 24:6812-22.
13. Szucs T. The socio-economic burden of influenza. J Antimicrob Chemother 1999; 44:11-5.
14. Kressin BW, Hallauer JF. Ökonomische Bedeutung der Schutzimpfung. Deutsches Ärzteblat 1999; 96:275-6.
15. Levy E. French economic evaluations of influenza and influenza vaccination. Pharmacoeconomics 1996; 9:62-6.
16. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007; 25:5086-96.
17. Lambert PH, Laurent PE. Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine 2008; 26:3197-208.
18. Nicolas JF, Guy B. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines 2008; 7:1201-14.
19. Laurent PE, Bonnet S, Alchas P, Regolini P, Mikszta JA, Pettis R, et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 2007; 25:8833-42.
20. European Agency for the Evaluation of Medicinal Products. Note for guidance on harmonization of requirements for influenza vaccines. 12 March 1997 http://www.emea.europa.eu/pdfs/human/bwp/021496en.pdf Accessed 2009.
21. Arnoux S, Weinberger C, Gessner BD. Vaccinepreventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use. Vaccine 2007; 25:7720-31.
22. Delore V, Salamand C, Marsh G, Arnoux S, Pepin S, Saliou P. Long-term clinical trial safety experience with the inactivated split influenza vaccine, Vaxigrip. Vaccine 2006; 4:1586-92.
23. Leroux-Roels I, Vets E, Freese R, Seiberling M, Weber F, Salamand C, et al. Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults. Vaccine 2008; 26:6614-9.
24. Pengsaa K, Limkittikul K, Sabchareon A, Ariyasriwatana C, Chanthavanich P, Attanath P, Malerczyk C. A threeyear clinical study on immunogenicity, safety and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine. Pediatr Infect Dis J 2009; 28:335-7.
25. Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 2008; 198:650-8.
26. Chau KF, Cheng YL, Tsang DN, Choi KS, Wong KM, Chak WL, et al. Efficacy and side effects of intradermal hepatitis B vaccination in CAPD patients: a comparison with the intramuscular vaccination. Am J Kidney Dis 2004; 43:910-7.
27. Palmer DF, Dowdle WR, Coleman MT, Shild GC. U.S. Dept. Hlth., Ed. Welfare P.H.S. Atlanta. Advanced laboratory technicals for immunological diagnostic. Immunology ser. nR 6, Procedural guide, Part 2: Haemagglutination - inhibition test 1975; 25-62.
28. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998; 17:857-72.